Biomarin Pharmaceutical Inc. (BMRN)
Market Closed
1 Sep, 20:00
$
64. 84
-0.39
-0.5979%
After Hours
$
+2.4 +3.7014% 67. 24
12.5B Market Cap
126.18 P/E Ratio
- Div Yield
1.78M Volume
1 Eps
$ 65.23
Previous Close 
Want to track BMRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biomarin Pharmaceutical Inc. (BMRN) Statistics
Valuation metrics
Market Cap 12.5B
Enterprise value 15.83B
Trailing P/E (ttm) 170.17
Forward P/E 8.4
PEG ratio -1.91
Price/Sales (ttm) 3.67
Price/Book (mrq) 1.97
Enterprise Value/Revenue 4.65
Enterprise Value/EBITDA 41.03
Overview
Shares outstanding 193.27M
Float 192.17M
Shares short 10.79M
% Held by insiders 0%
% Held by institutions 1.03%
Average volume (10 days) 1.1M
Average volume (90 days) 1.82M
Price summary
52-Week low 49.26
52-Week high 70.98
Beta 0.23
50-Day moving average 61.4
200-Day moving average 56.87
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) 3.24B
Revenue per share (ttm) 17.65
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 1.66B
EBITDA 572.94M
Net income to common (ttm) 268.74M
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 2.22B
Total cash per share (mrq) 4.53
Total debt (mrq) 1.44B
Total Debt/Equity (mrq) 0.66
Current ratio (mrq) 2.39%
Book value per share (mrq) 32.76
Cash Flow
Cash flow statement 874.25M
Levered free cash flow (LFCF) 459.42M
